Visceral adiposity and increased inflammation often accompany aging
Accessible and Affordable Wellness REVIV makes Vitamin B12 shots and IV therapies containing B12 accessible and affordable, without compromising on quality
Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
B12/MIC can be either a short-term or a long-term tool to add to your longevity toolkit
Cycle Length 8 to 12 weeks is the most common Tesofensine cycle Some advanced users run intermittent 5-days-on/2-days-off protocols to manage tolerance Take fasted in the morning to blunt appetite throughout the day and avoid sleep disruption Tapering and Tolerance Tolerance may build after ~46 weeks at higher doses Consider cycling off for 4 weeks or switching to a peptide (like Tesamorelin) if hunger control declines Tesofensine is generally well-tolerated at lower doses but should always be started conservatively especially for users new to nootropic or appetite-modulating compounds
If you arent able to get enough from your diet or have trouble absorbing enough from the food you consume, you might suffer from B-12 deficiency